Xencor (XNCR) Depreciation & Amortization (CF) (2013 - 2026)

Xencor's (XNCR) quarterly Depreciation & Amortization (CF) came in at $2.6 million in Q1 2026, down 4.68% year-on-year from $2.7 million in Q1 2025, and little changed on a QoQ basis from $2.6 million in Q4 2025.

Xencor (XNCR) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $2.6 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 4.68% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $10.4 million, a 11.72% decrease from a year earlier, with the FY2025 full-year figure at $10.5 million, down 13.17% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $2.6 million, roughly flat from $2.6 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for XNCR reached as high as $3.2 million in Q4 2023 and fell as low as $2.2 million in Q4 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $2.7 million across 5 years, with a median of $2.7 million in 2025.
  • Across the five-year window, Depreciation & Amortization (CF) surged 49.51% in 2023 and decreased 15.23% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $2.2 million in 2022, then soared by 49.51% to $3.2 million in 2023, then fell by 7.25% to $3.0 million in 2024, then retreated by 13.93% to $2.6 million in 2025, then decreased by 0.39% to $2.6 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Xencor 1.47 Bn 1.09 Bn - 2.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.57 Mn
Mar 31, 2026 2.57 Mn
Dec 31, 2025 2.58 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.59 Mn
Sep 30, 2025 2.59 Mn
Jun 30, 2025 2.65 Mn
Jun 30, 2025 2.65 Mn
Mar 31, 2025 2.69 Mn
Mar 31, 2025 2.69 Mn
Dec 31, 2024 2.99 Mn
Dec 31, 2024 2.99 Mn
Sep 30, 2024 3.05 Mn
Sep 30, 2024 3.05 Mn
Jun 30, 2024 3.02 Mn
Jun 30, 2024 3.02 Mn
Mar 31, 2024 3.04 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 3.23 Mn
Dec 31, 2023 3.23 Mn